Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Autoimmune Diseases
Biotech
Boehringer's deal frenzy continues with $570M autoimmune pact
The German pharma is turning to established partner CDR-Life for a new trispecific autoimmune antibody.
Darren Incorvaia
Nov 4, 2025 8:00am
Celltrion pens $744M pact for 2 preclinical autoimmune drugs
Nov 4, 2025 6:15am
Boehringer returns to Kyowa with €640M pact for autoimmune drug
Oct 30, 2025 6:03am
Zenas autoimmune drug prompts 95% drop in lesions in MS study
Oct 27, 2025 9:25am
Diabetes drug soothes brain inflammation in female mice with MS
Oct 15, 2025 6:16pm
Kyorin pens $105M pact for Japan rights to Hinge's lupus drug
Oct 1, 2025 6:40am